Výsledky vyhledávání

Everolimus-Eluting Stents Versus Sirolimus- or Paclitaxel-Eluting Stents: Two-Year Results from the Guthrie Health Off-Label Stent (GHOST) Registry

Autor: Pam Orshaw, Judy Boura, Neil Harjai, Kishore J. Harjai, Sreekanth Kondareddy, Brian Pinkosky

Publikováno v: Journal of Interventional Cardiology. 26:153-162

Objectives We sought to compare the safety and effectiveness of everolimus-eluting stents (EES) versus first generation drug-eluting stents (FG-DES; sirolimus-eluting stent [SES] or paclitaxel-eluting stent [PES]). Methods In 2,126 patients undergoin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd2f8ddffdc8e1ee31b0a45535647a55
https://doi.org/10.1111/j.1540-8183.2013.12016.x

Zobrazit plný text záznamu

Plný text ve formátu HTML

Long-Term Safety and Effectiveness of Drug-Eluting Stents Compared to Bare Metal Stents in ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label Stent (GHOST) Registry

Autor: Kishore J. Harjai, Sudhakar Sattur, Pam Orshaw, Judy Boura

Publikováno v: Journal of Interventional Cardiology. 25:118-125

Background: Multiple randomized trials and observational studies have shown drug-eluting stents (DES) to be safe and effective at 3-year follow-up in stent thrombosis (ST)-segment elevation myocardial infarction (STEMI) treated with primary percutane

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::acd46e6d187f0599e0f6242726e971b6
https://doi.org/10.1111/j.1540-8183.2011.00703.x

Zobrazit plný text záznamu

Low-Dose versus High-Dose Aspirin after Percutaneous Coronary Intervention: Analysis from the Guthrie Health Off-Label StenT (GHOST) Registry

Autor: Kishore J. Harjai, Chetan Shenoy, Samer Usmani, Judy Boura, Maninder Singh, Pam Orshaw, Rajendra H. Mehta

Publikováno v: Journal of Interventional Cardiology. 24:307-314

Background: The optimal dose of aspirin therapy after percutaneous coronary intervention (PCI) remains unclear. We sought to compare the effectiveness and safety of low and high doses of aspirin in preventing adverse outcomes after PCI. Methods: We s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29674fbf2a9e5ede1187573d70994160
https://doi.org/10.1111/j.1540-8183.2011.00627.x

Zobrazit plný text záznamu

Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry

Autor: Kishore J, Harjai, Sreekanth, Kondareddy, Brian, Pinkosky, Neil, Harjai, Pam, Orshaw, Judy, Boura

Publikováno v: Journal of interventional cardiology. 26(2)

We sought to compare the safety and effectiveness of everolimus-eluting stents (EES) versus first generation drug-eluting stents (FG-DES; sirolimus-eluting stent [SES] or paclitaxel-eluting stent [PES]).In 2,126 patients undergoing percutaneous coron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00278c7d4efb410bafb1c7bd41caae90
https://pubmed.ncbi.nlm.nih.gov/23363439

Zobrazit plný text záznamu

Plný text ve formátu HTML

Abstract 332: Indeterminate Troponins are Predictive of Worse Long-term Outcomes in Patients With Unstable Angina

Autor: Sudhakar Sattur, Kishore Harjai, Pam Orshaw, Mukesh Garg

Publikováno v: Circulation: Cardiovascular Quality and Outcomes. 5

Background: Indeterminate troponins (IT) are known to be associated with worse in-hospital and short-term clinical outcomes. However the effect of IT on long-term clinical outcomes has not been studied. Methods: We included all patients with unstable

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e282e31c5764ee4e744be0328339c7db
https://doi.org/10.1161/circoutcomes.5.suppl_1.a332

Zobrazit plný text záznamu

Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents in ST elevation myocardial infarction: findings from the Guthrie Health Off-label Stent (GHOST) Registry

Autor: Sudhakar, Sattur, Pam, Orshaw, Judy, Boura, Kishore J, Harjai

Publikováno v: Journal of interventional cardiology. 25(2)

Multiple randomized trials and observational studies have shown drug-eluting stents (DES) to be safe and effective at 3-year follow-up in stent thrombosis (ST)-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4671a355f88f7d4d127d35c3d5874b82
https://pubmed.ncbi.nlm.nih.gov/22324820

Zobrazit plný text záznamu

Low-dose versus high-dose aspirin after percutaneous coronary intervention: analysis from the guthrie health off-label StenT (GHOST) registry

Autor: Kishore J, Harjai, Chetan, Shenoy, Pam, Orshaw, Samer, Usmani, Maninder, Singh, Judy, Boura, Rajendra H, Mehta

Publikováno v: Journal of interventional cardiology. 24(4)

The optimal dose of aspirin therapy after percutaneous coronary intervention (PCI) remains unclear. We sought to compare the effectiveness and safety of low and high doses of aspirin in preventing adverse outcomes after PCI.We studied 2,820 consecuti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::41a934711a6375e7e4b517bc1beb8a4e
https://pubmed.ncbi.nlm.nih.gov/21790788

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání